Literature DB >> 28980737

GPR120 is not required for ω-3 PUFAs-induced cell growth inhibition and apoptosis in breast cancer cells.

Shenglong Zhu1,2,3, Xiaowei Jiang4, Siyuan Jiang5, Guangxiao Lin1,2, Jianping Gong4, Wei Chen1,2,6,7, Zhao He1,2,3, Yong Q Chen1,2,3,6,8.   

Abstract

Intake of ω-3 PUFAs reduces the frequency of breast cancer, and GPR120 receptor transduces ω-3 PUFAs signaling to increase insulin sensitivity in mice, but whether GPR120 mediates ω-3 PUFAs signaling to inhibit breast carcinogenesis is currently unknown. In the present study, we found that GPR120 is highly expressed in human breast cancerous tissues but not adjacent normal tissue. Knockdown of GPR120 by siRNA in breast cancer cells significantly reduced cell growth, and dramatically increased ω-3 FFA-induced cell growth inhibition and apoptosis. Thus, these observations indicated that GPR120 promotes breast cancer cell growth, whereas ω-3 PUFA-induce breast cancer cell apoptosis independently of GPR120.
© 2017 International Federation for Cell Biology.

Entities:  

Keywords:  GPR120; breast cancer; ω-3 PUFAs

Mesh:

Substances:

Year:  2017        PMID: 28980737     DOI: 10.1002/cbin.10883

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Free fatty acid receptor 4 deletion attenuates colitis by modulating Treg Cells via ZBED6-IL33 pathway.

Authors:  Shenglong Zhu; Jingwei Zhang; Xuan Jiang; Wei Wang; Yong Q Chen
Journal:  EBioMedicine       Date:  2022-05-16       Impact factor: 11.205

2.  Fatty acid receptor GPR120 promotes breast cancer chemoresistance by upregulating ABC transporters expression and fatty acid synthesis.

Authors:  Xue Wang; Songbing He; Yuting Gu; Qiwei Wang; Xiao Chu; Min Jin; Liang Xu; Qiong Wu; Qianjun Zhou; Bei Wang; Yanyun Zhang; Hui Wang; Leizhen Zheng
Journal:  EBioMedicine       Date:  2019-02-06       Impact factor: 8.143

3.  Free Fatty Acids Promote the Development of Prostate Cancer by Upregulating Peroxisome Proliferator-Activated Receptor Gamma.

Authors:  Xiaodan Ha; Jingzhou Wang; Cuizhe Wang; Keru Chen; Yuchun Deng; Xueting Zhang; Jiale Feng; Xue Li; Jiaojiao Zhu; Yinghua Ma; Tongtong Qiu; Jianxin Xie; Jun Zhang
Journal:  Cancer Manag Res       Date:  2020-02-24       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.